Zymeworks ZYME Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value

Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value at other companies

ZymeworksZYME

8—

KEE

Keel Infrastructure Corp. Common StockKEEL

$1.08+4.9%

BeldenBDC

$39.44+80.5%

CHE

ChemedCHE

85.8-25.1%

KEE

Keel Infrastructure Corp. Common StockKEEL

$0.72-35.7%

HTF

Heartflow, Inc. Common StockHTFL

15.9+124%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value?: Zymeworks (ZYME) reported sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value of 8 in Q4 2025.
What does sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value mean?: The weighted-average grant date fair value of stock options that have vested during the reporting period. This metric helps quantify the expense recognized in the financial statements related to the vesting of previously granted equity incentives.